Unexplained Hyperthyroglobulinemia in Differentiated Thyroid Cancer Patients as an Indication for Radioiodine Adjuvant Therapy: A Prospective Multicenter Study

医学 甲状腺球蛋白 甲状腺癌 内科学 前瞻性队列研究 甲状腺 胃肠病学 辅助治疗 放射性碘疗法 危险分层 队列 佐剂 疾病 癌症 内分泌学
作者
Lin Cheng,Ri Sa,Qiong Luo,Hao Fu,Yuchen Jin,Linglin Tang,Yi An Yang,Chunjing Yu,Libo Chen
出处
期刊:Journal of nuclear medicine [Society of Nuclear Medicine and Molecular Imaging]
卷期号:62 (1): 62-68 被引量:27
标识
DOI:10.2967/jnumed.120.243642
摘要

The management for totally thyroidectomized differentiated thyroid cancer (TT-DTC) patients with unexplained hyperthyroglobulinemia remains indeterminate because of evidence scarcity. This multicenter study aimed at prospectively evaluating the response to radioiodine (131I) adjuvant therapy (RAT) and its potential role in risk stratification and causal clarification. Methods: TT-DTC patients with stimulated serum thyroglobulin levels greater than 10 ng/mL but no structurally evident disease were consecutively enrolled in 5 tertiary-care institutions. After the administration of 5.55 GBq of 131I, the risk of persistent, recurrent, or metastatic differentiated thyroid cancer (prmDTC) was compared with that before RAT. The causes of hyperthyroglobulinemia were explored—and the response to RAT assessed—6–12 mo after RAT. The change in suppressed thyroglobulin level was reported. Results: A cohort of 254 subjects with a median stimulated thyroglobulin level of 27.1 ng/mL was enrolled for the analyses. Immediately after RAT, low, intermediate, and high risk were identified in 5.9%, 88.6%, and 5.5% patients, respectively, with no significant difference in risk stratification compared with that before RAT (P = 0.952). During the follow-up (median, 10.6 mo), hyperthyroglobulinemia was ultimately attributed to a thyroid remnant, biochemical disease, and structural or functional disease in 17.3%, 54.3%, and 28.4% of subjects, respectively. In addition, responses that were excellent, indeterminate, biochemically incomplete, and structurally or functionally incomplete were achieved in 18.1%, 27.2%, 36.2%, and 18.5% of patients, respectively. Notably, the distribution for either cause of hyperthyroglobulinemia or response to RAT was comparable among the 3 postoperative risk groups. Suppressed thyroglobulin levels in patients who merely received RAT declined significantly over time. Conclusion: Our study demonstrated that over 90% of TT-DTC patients with unexplained hyperthyroglobulinemia are stratified as being at intermediate to high risk, and RAT using 5.55 GBq of 131I reveals biochemical, functional, or structural disease and yields a non–structurally or –functionally incomplete response in more than 80% patients, suggesting that TT-DTC patients with unexplained hyperthyroglobulinemia are explicit candidates for RAT.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
cen发布了新的文献求助10
刚刚
在水一方的应助被开心德地采纳,获得10
1秒前
TEDDY发布了新的文献求助10
1秒前
2秒前
2秒前
李薇完成签到,获得积分20
2秒前
2秒前
3秒前
蛤蛤哈哈给蛤蛤哈哈的求助进行了留言
4秒前
嘻嘻嘻完成签到,获得积分10
4秒前
CTA发布了新的文献求助30
5秒前
愉快自中完成签到,获得积分10
5秒前
研友_VZG7GZ的应助被陈向洋采纳,获得10
6秒前
shidandan完成签到 ,获得积分10
8秒前
小俊发布了新的文献求助10
8秒前
10秒前
我是谁的应助被zero采纳,获得30
10秒前
小阿俊完成签到,获得积分10
11秒前
金金完成签到,获得积分10
11秒前
12秒前
情怀的应助被poi采纳,获得10
14秒前
Owen的应助被开心德地采纳,获得10
15秒前
17秒前
18秒前
18秒前
Orange的应助被yuko采纳,获得10
19秒前
Gjorv完成签到 ,获得积分10
19秒前
19秒前
顺顺利利的应助被meimei3313采纳,获得50
23秒前
molihuakai的应助被开心德地采纳,获得10
23秒前
科研通AI65的应助被神棍喜来乐采纳,获得10
24秒前
XR发布了新的文献求助10
24秒前
24秒前
烟花的应助被xuhang采纳,获得10
25秒前
我是老大的应助被jiajia采纳,获得10
27秒前
娜娜子欧完成签到,获得积分10
27秒前
赘婿的应助被wg采纳,获得10
28秒前
内向的语雪完成签到,获得积分10
29秒前
arniu2008的应助被唐宇航采纳,获得80
29秒前
dingyang41发布了新的文献求助10
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188885
求助须知:如何正确求助?哪些是违规求助? 9576442
关于积分的说明 21847777
捐赠科研通 7786897
什么是DOI,文献DOI怎么找? 3435446
关于科研通互助平台的介绍 2559654
邀请新用户注册赠送积分活动 2482383